SOR-C13 TFA, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC 50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel that is associated with malignancy and poor prognosis in breast cancer . SOR-C13 TFA has anti Appearance:Solid IC50& Target:TRPV6 14 nM (IC 50 ) In Vivo:SOR-C13 (i.p.; 400,600, 800mg/kg; daily; on days 1 to 12) TFA can effectively inhibit the growth of tumor in female NOD/SCID mice with SKOV-3 cell. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Anima Biological Activity:SOR-C13 TFA, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC 50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel that is associated with malignancy and poor prognosis in breast cancer . SOR-C13 TFA has anti
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
SOR-C13 TFA
CAS number：unknown molecular formula：C74H117F3N20O21
overview
compound introduction
Specs
| Chinese alias | SOR-C13三氟乙酸 | ||
| English alias | - | ||
| CAS number | unknown | molecular formula | C74H117F3N20O21 |
| molecular weight | 1679.84 g/mol | Exact mass | ≥99% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
